Joseph R. Osborne, M.D., Ph.D.

Diagnostic Radiology

Locations and Appointments

Insurances Accepted

Please contact the doctor's office to verify that your insurance is accepted.

*Indicates this doctor is no longer accepting new patients with this insurance plan.

  • HMO
  • Medicare
  • PPO
  • CHP
  • Blue Access
  • Blue Connection
  • EPO
  • HMO
  • Mediblue (Senior)
  • PPO
  • CBP
  • Medicaid
  • Medicare
  • Freedom
  • Liberty
  • Medicare Advantage
  • Metro/Core/Charter
  • Community Plan
  • Medicare
  • HMO
  • Medicare
Personal Statement

My vision for our Molecular Imaging and Therapeutics Service is to translate the best science into practice. This starts with a focus on clinical excellence, and developing a culture of mentorship of the junior faculty and trainees who will initiate the next practice-changing diagnostics beyond fluoro-deoxyglucose (FDG) positron emission tomography (PET). This next phase will require establishing viable, reimbursable therapeutics and establishing a firm connection with non-imaging sciences. Finally, we must also engage our patients and community to ensure that this advanced imaging meets the quality metrics that will clearly alter the practice of medicine. 

Biographical Info

Joseph Osborne M.D., Ph.D. is the Chief of Molecular Imaging and Therapeutics and a Professor of Radiology at Weill Cornell Medicine. He is an Attending Radiologist at NewYork-Presbyterian/Weill Cornell Medical Center. 

Dr. Osborne earned his M.D. at Columbia College of Physicians and Surgeons and his PhD in Biochemistry at Columbia’s Graduate School of Arts and Sciences in New York, NY. After an internship in the department of Internal Medicine at the Washington Hospital Center in Washington, D.C., Dr. Osborne completed his residency training in Diagnostic Radiology at Columbia Presbyterian Hospital followed by a fellowship training in Nuclear Medicine. Dr. Osborne also completed post-doctoral training at Memorial Sloan Kettering Cancer Center in New York, NY.

Dr. Osborne is the Head of the Radiology Health Equity Lab where his goal as a physician-scientist is to promote practical value-added  imaging that is closely aligned with precision medicine. In line with this goal, he is currently the principle investigator on an Academic Industrial Partnership RO1 grant “A new technique to make 68Ga-labeled pharmaceuticals widely available for clinical use.”

He also has extramural duties as the Chair of the Innovation award review panel for the Damon Runyon Cancer Foundation.

Over his career, he has had a strong leadership role in physician training and mentoring, serving as Program Director of Nuclear Medicine Residency Program at NewYork-Presbyterian/Weill Cornell Medical Center as well as an additional three years in a similar role at Memorial Sloan Kettering.

Board Certifications
American Board of Nuclear Medicine
American Board of Radiology (Diagnostic Radiology)
Clinical Expertise
Molecular Imaging
Magnetic Resonance Imaging
Nuclear Radiology
Body MRI
MRI of the Abdomen
MRI of the Pelvis
MRI Liver
PET Scan
Ultrasound Imaging
PET-CT Entire Body
Positron Emission Tomography
Bone Density Test
Bone Scan
Osteoporosis Screening
Radionuclide Therapy For Metastases of Bone
Cancer Screening
  • M.D., Ph.D.
    Columbia University College of Physicians and Surgeons
  • B.S.
    Brown University
  • Attending Radiologist
    NewYork-Presbyterian Hospital
  • Professor of Radiology
    Weill Cornell Medical College, Cornell University

Relationships and collaborations with for-profit and not-for profit organizations are of vital importance to our faculty because these exchanges of scientific information foster innovation. As experts in their fields, WCM physicians and scientists are sought after by many organizations to consult and educate. WCM and its faculty make this information available to the public, thus creating a transparent environment.

No External Relationships Reported